Cargando…

The predictive significance of a 5-m6A RNA methylation regulator signature in colorectal cancer

Colorectal cancer attacks the colon or rectum, with increasing morbidity and mortality globally. The RNA modification 6-methyladenine (m6A) is related to RNA modifications, playing a critical role in colorectal cancer. We aimed to identify prognostic signatures for colorectal cancer using risk predi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Dan, Wu, Guotao, Yang, Lichao, Wu, Qiang, Yuan, Lianwen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10550633/ https://www.ncbi.nlm.nih.gov/pubmed/37810844 http://dx.doi.org/10.1016/j.heliyon.2023.e20172

Ejemplares similares

METTL3 overexpression aggravates LPS-induced cellular inflammation in mouse intestinal epithelial cells and DSS-induced IBD in mice
por: Yang, Lichao, et al.
Publicado: (2022)

Development and Validation of an m6A RNA Methylation Regulator-Based Signature for Prognostic Prediction in Cervical Squamous Cell Carcinoma
por: Pan, Jingxin, et al.
Publicado: (2020)

The m(6)A-Related mRNA Signature Predicts the Prognosis of Pancreatic Cancer Patients
por: Meng, Zibo, et al.
Publicado: (2020)

Identification and Validation of an m6A-Related LncRNA Signature to Predict Progression-Free Survival in Colorectal Cancer
por: Zhang, Yong, et al.
Publicado: (2022)

A methylation‐based mRNA signature predicts survival in patients with gastric cancer
por: Li, Yang, et al.
Publicado: (2020)

An integrated lncRNA, microRNA and mRNA signature to improve prognosis prediction of colorectal cancer
por: Xiong, Yongfu, et al.
Publicado: (2017)

Prognostic Value of an m6A RNA Methylation Regulator-Based Signature in Patients with Hepatocellular Carcinoma
por: Wu, Xiaomin, et al.
Publicado: (2020)

m6Acomet: large-scale functional prediction of individual m(6)A RNA methylation sites from an RNA co-methylation network
por: Wu, Xiangyu, et al.
Publicado: (2019)

Development and Validation of an m6A RNA Methylation Regulators-Based Signature for Predicting the Prognosis of Adrenocortical Carcinoma
por: Shen, Chengquan, et al.
Publicado: (2021)

Characterization of m(6)A RNA Methylation Regulators Predicts Survival and Immunotherapy in Lung Adenocarcinoma
por: Zhu, Minggao, et al.
Publicado: (2021)

NEK7 interacts with NLRP3 to modulate the pyroptosis in inflammatory bowel disease via NF-κB signaling
por: Chen, Xueliang, et al.
Publicado: (2019)

Clinical significance of DNA methylation mRNA levels of TET family members in colorectal cancer
por: Rawłuszko-Wieczorek, Agnieszka Anna, et al.
Publicado: (2015)

Development and validation of an m6A RNA methylation regulator-based signature for the prediction of prognosis and immunotherapy in cutaneous melanoma
por: Li, Tingting, et al.
Publicado: (2023)

Expression and significance of m6A-RNA-methylation in oral cancer and precancerous lesion
por: Qin, Zhiming, et al.
Publicado: (2023)

The significance of m6A RNA methylation regulators in predicting the prognosis and clinical course of HBV-related hepatocellular carcinoma
por: Fang, Qiongxuan, et al.
Publicado: (2020)

The m6A/m5C/m1A Regulated Gene Signature Predicts the Prognosis and Correlates With the Immune Status of Hepatocellular Carcinoma
por: Li, Dan, et al.
Publicado: (2022)

A robust 6-mRNA signature for prognosis prediction of pancreatic ductal adenocarcinoma
por: Zhou, Chenhao, et al.
Publicado: (2019)

Role of PCIF1‐mediated 5′‐cap N6‐methyladeonsine mRNA methylation in colorectal cancer and anti‐PD‐1 immunotherapy
por: Wang, Lingling, et al.
Publicado: (2022)

Gene Signatures and Prognostic Values of m6A RNA Methylation Regulators in Ovarian Cancer
por: Han, Xiao, et al.
Publicado: (2020)

Development and validation of m6A RNA methylation regulators-based signature in lung adenocarcinoma
por: Guo, Wei, et al.
Publicado: (2021)

Four m6A RNA Methylation Gene Signatures and Their Prognostic Values in Lung Adenocarcinoma
por: Wang, Yuzhu, et al.
Publicado: (2022)

An m6A/m5C/m1A/m7G-Related Long Non-coding RNA Signature to Predict Prognosis and Immune Features of Glioma
por: Shao, Dongqi, et al.
Publicado: (2022)

Identification of a m(6)A RNA methylation regulators-based signature for predicting the prognosis of clear cell renal carcinoma
por: Chen, Jing, et al.
Publicado: (2020)

An m6A-Related lncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma
por: Zhang, Zhenyu, et al.
Publicado: (2022)

N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients
por: Song, Wei, et al.
Publicado: (2021)

Cross-Talk Between m(6)A- and m(5)C-Related lncRNAs to Construct a Novel Signature and Predict the Immune Landscape of Colorectal Cancer Patients
por: Song, Wei, et al.
Publicado: (2022)

Developing an m5C regulator–mediated RNA methylation modification signature to predict prognosis and immunotherapy efficacy in rectal cancer
por: Zhang, Rixin, et al.
Publicado: (2023)

The lncRNA epigenetics: The significance of m6A and m5C lncRNA modifications in cancer
por: Cusenza, Vincenza Ylenia, et al.
Publicado: (2023)

Construction and Validation of an m6A RNA Methylation Regulators-Based Prognostic Signature for Esophageal Cancer
por: Xu, Li-chao, et al.
Publicado: (2020)

A newly defined risk signature, consisting of three m(6)A RNA methylation regulators, predicts the prognosis of ovarian cancer
por: Fan, Lili, et al.
Publicado: (2020)

Establishment of a Risk Signature Based on m6A RNA Methylation Regulators That Predicts Poor Prognosis in Renal Cell Carcinoma
por: Wei, Jingsun, et al.
Publicado: (2021)

Sequence- and structure-selective mRNA m(5)C methylation by NSUN6 in animals
por: Liu, Jianheng, et al.
Publicado: (2020)

Sequence- and structure-specific cytosine-5 mRNA methylation by NSUN6
por: Selmi, Tommaso, et al.
Publicado: (2020)

Identification of the Signature Associated With m(6)A RNA Methylation Regulators and m(6)A-Related Genes and Construction of the Risk Score for Prognostication in Early-Stage Lung Adenocarcinoma
por: Guo, Bingzhou, et al.
Publicado: (2021)

Signature of m5C-Related lncRNA for Prognostic Prediction and Immune Responses in Pancreatic Cancer
por: Liu, Xiangrong, et al.
Publicado: (2022)

Identification of m6A‐related lncRNAs as prognostic signature within colon tumor immune microenvironment
por: Cao, Lichao, et al.
Publicado: (2023)

Effect of N6-methyladenosine methylation-related gene signature for predicting the prognosis of hepatocellular carcinoma patients
por: Zheng, Xinyu, et al.
Publicado: (2023)

The development of a novel signature based on the m(6)A RNA methylation regulator-related ceRNA network to predict prognosis and therapy response in sarcomas
por: Li, Huling, et al.
Publicado: (2022)

N6‐methyladenosine demethylase ALKBH5 suppresses colorectal cancer progression potentially by decreasing PHF20 mRNA methylation
por: Zhang, Zhen, et al.
Publicado: (2022)

m6A RNA methylation regulator-related signatures exhibit good prognosis prediction ability for head and neck squamous cell carcinoma
por: Zhai, Yujia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gu96p1lnn2r03t7dh38s1vb21q